Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
, , , ,
Tirzepatide is a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist a single molecule that activates two separate hormone receptor systems involved in appetite, metabolism, and blood sugar regulation
Newly released survey data revealed the following key trends for GLP-1 drug coverage: 51% of employers provide coverage for diabetes only (a decrease from 56% in 2025 and 66% in 2024) 37% provide coverage for both diabetes and weight loss (on the rise from 31% in 2025 and 17% in 2024) 12% cover GLP-1 drugs for other conditions (sleep apnea, cardiovascular disease, etc.)
Tirzepatide controls your blood sugar levels, reduces your appetite, and slows your stomach emptying
When prescribing Tirzepatide for weight loss, healthcare providers need to consider the patients specific medical conditions
US$ 28.42
US$ 26.58
US$ 29.00
US$ 24.62
